Ribosome inhibition by C9ORF72-ALS/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM [preprint]
Authors
Loveland, Anna B.Svidritskiy, Egor
Susorov, Denis
Lee, Soojin
Park, Alexander
Demo, Gabriel
Gao, Fen-Biao
Korostelev, Andrei A.
UMass Chan Affiliations
Graduate School of Biomedical SciencesDepartment of Neurology
Department of Biochemistry and Molecular Pharmacology
RNA Therapeutics Institute
Document Type
PreprintPublication Date
2020-08-31Keywords
Biochemistryribosomes
Toxic dipeptide repeat (DPR) proteins
C9ORF72 gene
C9ORF72 gene
amyotrophic lateral sclerosis
ALS
frontotemporal dementia
FTD
Amino Acids, Peptides, and Proteins
Biochemistry
Molecular Biology
Nervous System Diseases
Structural Biology
Metadata
Show full item recordAbstract
Toxic dipeptide repeat (DPR) proteins are produced from expanded G4C2 hexanucleotide repeats in the C9ORF72 gene, which cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Two DPR proteins, poly-PR and poly-GR, repress cellular translation but the molecular mechanism remains unknown. Here we show that poly-PR and poly-GR of ≥ 20 repeats inhibit the ribosome’s peptidyl-transferase activity at nanomolar concentrations, comparable to specific translation inhibitors. High-resolution cryo-EM structures reveal that poly-PR and poly-GR block the polypeptide tunnel of the ribosome, extending into the peptidyl-transferase center. Consistent with these findings, the macrolide erythromycin, which binds in the tunnel, competes with the DPR proteins and restores peptidyl-transferase activity. Our results demonstrate that strong and specific binding of poly-PR and poly-GR in the ribosomal tunnel blocks translation, revealing the structural basis of their toxicity in C9ORF72-ALS/FTD.Source
bioRxiv 2020.08.30.274597; doi: https://doi.org/10.1101/2020.08.30.274597. Link to preprint on bioRxiv.
DOI
10.1101/2020.08.30.274597Permanent Link to this Item
http://hdl.handle.net/20.500.14038/29604Notes
This article is a preprint. Preprints are preliminary reports of work that have not been certified by peer review.
Related Resources
Now published in Nature Communications, doi:10.1038/s41467-022-30418-0Rights
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.Distribution License
http://creativecommons.org/licenses/by-nc-nd/4.0/ae974a485f413a2113503eed53cd6c53
10.1101/2020.08.30.274597
Scopus Count
Except where otherwise noted, this item's license is described as The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.